Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA's NDA And BLA Approvals

29 Dec 2017

Original new drugs and biologics recently approved by US FDA.

Related Content

Spark's Early Christmas Present: US FDA Approves Luxturna For Vision Loss

19 Dec 2017

FDA Bests Annual Novel Drug Approval Record With Four Oks In One Week

22 Dec 2017

Additional Topics

United States Approvals Regulation Regenerative Medicine BioPharmaceutical Metabolic Disorders Ophthalmic

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.